<html><head><meta content="text/html; charset=UTF-8" http-equiv="content-type"><style type="text/css">.lst-kix_dk8rt853p4k9-3>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-3}ol.lst-kix_dk8rt853p4k9-5.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-5 0}ol.lst-kix_dk8rt853p4k9-2.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-2 0}ul.lst-kix_5f4ryaaz99dq-2{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-3{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-0{list-style-type:none}ol.lst-kix_dk8rt853p4k9-1{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-1{list-style-type:none}ol.lst-kix_dk8rt853p4k9-0{list-style-type:none}ol.lst-kix_dk8rt853p4k9-3{list-style-type:none}ol.lst-kix_dk8rt853p4k9-2{list-style-type:none}ul.lst-kix_8msg9554alny-7{list-style-type:none}ol.lst-kix_dk8rt853p4k9-5{list-style-type:none}ul.lst-kix_8msg9554alny-8{list-style-type:none}ol.lst-kix_dk8rt853p4k9-4{list-style-type:none}ol.lst-kix_dk8rt853p4k9-7{list-style-type:none}ol.lst-kix_dk8rt853p4k9-6{list-style-type:none}ol.lst-kix_dk8rt853p4k9-8{list-style-type:none}ul.lst-kix_8msg9554alny-1{list-style-type:none}ul.lst-kix_8msg9554alny-2{list-style-type:none}ol.lst-kix_dk8rt853p4k9-1.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-1 0}ul.lst-kix_8msg9554alny-0{list-style-type:none}ul.lst-kix_8msg9554alny-5{list-style-type:none}ul.lst-kix_8msg9554alny-6{list-style-type:none}ul.lst-kix_8msg9554alny-3{list-style-type:none}.lst-kix_dk8rt853p4k9-2>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-2}ul.lst-kix_8msg9554alny-4{list-style-type:none}.lst-kix_5f4ryaaz99dq-5>li:before{content:"-  "}ul.lst-kix_5f4ryaaz99dq-6{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-7{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-4{list-style-type:none}ul.lst-kix_5f4ryaaz99dq-5{list-style-type:none}.lst-kix_dk8rt853p4k9-5>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-5}.lst-kix_dk8rt853p4k9-8>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-8}.lst-kix_5f4ryaaz99dq-6>li:before{content:"-  "}ul.lst-kix_5f4ryaaz99dq-8{list-style-type:none}.lst-kix_5f4ryaaz99dq-7>li:before{content:"-  "}.lst-kix_5f4ryaaz99dq-8>li:before{content:"-  "}ol.lst-kix_dk8rt853p4k9-8.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-8 0}.lst-kix_8msg9554alny-4>li:before{content:"-  "}ol.lst-kix_dk8rt853p4k9-0.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-0 0}.lst-kix_dk8rt853p4k9-6>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-6}.lst-kix_8msg9554alny-6>li:before{content:"-  "}.lst-kix_8msg9554alny-7>li:before{content:"-  "}.lst-kix_dk8rt853p4k9-0>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-0}.lst-kix_8msg9554alny-3>li:before{content:"-  "}ol.lst-kix_dk8rt853p4k9-7.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-7 0}.lst-kix_8msg9554alny-8>li:before{content:"-  "}.lst-kix_6zxsc1mlke1b-8>li:before{content:"-  "}.lst-kix_8msg9554alny-0>li:before{content:"-  "}.lst-kix_8msg9554alny-2>li:before{content:"-  "}.lst-kix_5f4ryaaz99dq-3>li:before{content:"-  "}.lst-kix_5f4ryaaz99dq-4>li:before{content:"-  "}.lst-kix_6zxsc1mlke1b-7>li:before{content:"-  "}.lst-kix_8msg9554alny-1>li:before{content:"-  "}.lst-kix_5f4ryaaz99dq-2>li:before{content:"-  "}.lst-kix_5f4ryaaz99dq-1>li:before{content:"-  "}ol.lst-kix_dk8rt853p4k9-4.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-4 0}.lst-kix_5f4ryaaz99dq-0>li:before{content:"-  "}.lst-kix_8msg9554alny-5>li:before{content:"-  "}ul.lst-kix_6zxsc1mlke1b-4{list-style-type:none}ol.lst-kix_dk8rt853p4k9-6.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-6 0}ul.lst-kix_6zxsc1mlke1b-5{list-style-type:none}ul.lst-kix_6zxsc1mlke1b-2{list-style-type:none}.lst-kix_dk8rt853p4k9-0>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-0,decimal) ". "}ul.lst-kix_6zxsc1mlke1b-3{list-style-type:none}ul.lst-kix_6zxsc1mlke1b-8{list-style-type:none}ul.lst-kix_6zxsc1mlke1b-6{list-style-type:none}.lst-kix_6zxsc1mlke1b-1>li:before{content:"-  "}ul.lst-kix_6zxsc1mlke1b-7{list-style-type:none}.lst-kix_dk8rt853p4k9-7>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-7}.lst-kix_dk8rt853p4k9-2>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-2,lower-roman) ". "}.lst-kix_6zxsc1mlke1b-0>li:before{content:"-  "}ul.lst-kix_6zxsc1mlke1b-0{list-style-type:none}.lst-kix_dk8rt853p4k9-1>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-1,lower-latin) ". "}ul.lst-kix_6zxsc1mlke1b-1{list-style-type:none}li.li-bullet-0:before{margin-left:-18pt;white-space:nowrap;display:inline-block;min-width:18pt}.lst-kix_dk8rt853p4k9-7>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-7,lower-latin) ". "}.lst-kix_dk8rt853p4k9-6>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-6,decimal) ". "}.lst-kix_dk8rt853p4k9-8>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-8,lower-roman) ". "}.lst-kix_6zxsc1mlke1b-4>li:before{content:"-  "}.lst-kix_6zxsc1mlke1b-6>li:before{content:"-  "}ol.lst-kix_dk8rt853p4k9-3.start{counter-reset:lst-ctn-kix_dk8rt853p4k9-3 0}.lst-kix_dk8rt853p4k9-1>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-1}.lst-kix_dk8rt853p4k9-4>li{counter-increment:lst-ctn-kix_dk8rt853p4k9-4}.lst-kix_6zxsc1mlke1b-5>li:before{content:"-  "}.lst-kix_dk8rt853p4k9-3>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-3,decimal) ". "}.lst-kix_dk8rt853p4k9-4>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-4,lower-latin) ". "}.lst-kix_6zxsc1mlke1b-2>li:before{content:"-  "}.lst-kix_dk8rt853p4k9-5>li:before{content:"" counter(lst-ctn-kix_dk8rt853p4k9-5,lower-roman) ". "}.lst-kix_6zxsc1mlke1b-3>li:before{content:"-  "}ol{margin:0;padding:0}table td,table th{padding:0}.c10{padding-top:16pt;padding-bottom:4pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c11{color:#000000;font-weight:700;text-decoration:none;vertical-align:baseline;font-size:18pt;font-family:"Arial";font-style:normal}.c27{padding-top:18pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:center}.c3{color:#000000;font-weight:700;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c23{padding-top:20pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:center}.c5{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:12pt;font-family:"Arial";font-style:normal}.c7{padding-top:18pt;padding-bottom:6pt;line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.c9{color:#000000;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c2{color:#434343;font-weight:400;text-decoration:none;vertical-align:baseline;font-size:14pt;font-family:"Arial";font-style:normal}.c28{color:#000000;text-decoration:none;vertical-align:baseline;font-size:16pt;font-family:"Arial";font-style:normal}.c13{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:center}.c0{padding-top:0pt;padding-bottom:0pt;line-height:1.0;orphans:2;widows:2;text-align:left}.c26{color:#000000;text-decoration:none;vertical-align:baseline;font-size:14pt;font-family:"Arial";font-style:normal}.c1{padding-top:0pt;padding-bottom:0pt;line-height:1.15;orphans:2;widows:2;text-align:left}.c21{color:#000000;text-decoration:none;vertical-align:baseline;font-size:20pt;font-family:"Arial";font-style:normal}.c8{color:#1155cc;font-weight:400;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c22{margin-left:18pt;padding-top:3pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c33{color:#242424;text-decoration:none;vertical-align:baseline;font-family:"Arial";font-style:normal}.c31{text-decoration:none;vertical-align:baseline;font-size:11pt;font-family:"Arial";font-style:normal}.c16{margin-left:36pt;padding-top:3pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c29{padding-top:3pt;padding-bottom:0pt;line-height:1.0;text-align:left}.c6{text-decoration-skip-ink:none;-webkit-text-decoration-skip:none;text-decoration:underline}.c32{background-color:#ffffff;max-width:468pt;padding:72pt 72pt 72pt 72pt}.c14{color:inherit;text-decoration:inherit}.c12{padding:0;margin:0}.c18{margin-left:36pt;padding-left:0pt}.c25{font-size:12pt}.c17{font-weight:700}.c30{color:#38761d}.c20{font-weight:400}.c15{color:#1155cc}.c24{margin-left:36pt}.c4{height:11pt}.c19{color:#6aa84f}.title{padding-top:0pt;color:#000000;font-size:26pt;padding-bottom:3pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}.subtitle{padding-top:0pt;color:#666666;font-size:15pt;padding-bottom:16pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}li{color:#000000;font-size:11pt;font-family:"Arial"}p{margin:0;color:#000000;font-size:11pt;font-family:"Arial"}h1{padding-top:20pt;color:#000000;font-size:20pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h2{padding-top:18pt;color:#000000;font-size:16pt;padding-bottom:6pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h3{padding-top:16pt;color:#434343;font-size:14pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h4{padding-top:14pt;color:#666666;font-size:12pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h5{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;orphans:2;widows:2;text-align:left}h6{padding-top:12pt;color:#666666;font-size:11pt;padding-bottom:4pt;font-family:"Arial";line-height:1.15;page-break-after:avoid;font-style:italic;orphans:2;widows:2;text-align:left}</style></head><body class="c32 doc-content"><p class="c13"><span style="overflow: hidden; display: inline-block; margin: 0.00px 0.00px; border: 0.00px solid #000000; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px); width: 217.00px; height: 217.00px;"><img alt="" src="images/image1.png" style="width: 217.00px; height: 217.00px; margin-left: 0.00px; margin-top: 0.00px; transform: rotate(0.00rad) translateZ(0px); -webkit-transform: rotate(0.00rad) translateZ(0px);" title=""></span></p><p class="c13"><span class="c17 c21">Unofficial Molecular Resident-to-Resident Guide</span></p><p class="c1 c4"><span class="c5"></span></p><p class="c1 c4"><span class="c5"></span></p><p class="c1"><span class="c5">Disclaimer: This is an unofficial resource. When in doubt, ask the attending. If something is wrong/inaccurate, let us know.</span></p><p class="c1 c4"><span class="c9"></span></p><p class="c13"><span class="c17 c26">Content</span></p><p class="c1"><span class="c6 c15"><a class="c14" href="https://www.google.com/url?q=https://gowustl.sharepoint.com/sites/MolecularRotation/SitePages/People.aspx&amp;sa=D&amp;source=editors&amp;ust=1697833802377016&amp;usg=AOvVaw0KO5LmaHdUWq6-HxT4qYxV">Molecular Faculty and Staff</a></span></p><p class="c1 c4"><span class="c9"></span></p><p class="c22"><span class="c6 c15"><a class="c14" href="#h.nbug08fhh5bg">Resident Expectations</a></span></p><p class="c22"><span class="c6 c15"><a class="c14" href="#h.ajk3ddkrgmav">Navigating Sharepoint</a></span></p><p class="c29"><span class="c6 c15 c20"><a class="c14" href="#h.ozsgdk265297">Molecular Diagnostics Lab (MDL)</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.f8wedwkh0s6n">MDL Call</a></span></p><p class="c22"><span class="c6 c15"><a class="c14" href="#h.nx0fwq1al5e1">Hematologic Molecular Algorithm (HMA)</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.p27u1n7bawyb">Chromoseq</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.b3rjvrxu75bb">Clonoseq</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.bhd37n9yfnmd">FLT3</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.hj8biuoni1yg">Myeloseq</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.40ecygjfzu2r">Tempus</a></span></p><p class="c22"><span class="c6 c15"><a class="c14" href="#h.63fntkqzyzpf">Molecular Sendout Testing (alphabetical order)</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.ob6ahw6piz0m">Apolipoprotein E</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.g0v069w1pmuk">Apolipoprotein L1</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.5w6ymsreoh2t">CYP450 family sequencing</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.rkhw4fiquozv">DPYD Genotype</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.scwhztbhe897">Huntington Disease Genetic Testing</a></span></p><p class="c29"><span class="c6 c20 c15"><a class="c14" href="#h.g16feqege86v">Next Generation Sequencing (NGS)</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.9zwhjumms2iw">Myeloseq</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.cicg7ym4qsgc">Chromoseq</a></span></p><p class="c16"><span class="c6 c15"><a class="c14" href="#h.th2pfcqzuiwd">Cytogenetics</a></span></p><h2 class="c7" id="h.nbug08fhh5bg"><span class="c28 c20">Resident Expectations</span></h2><p class="c1"><span class="c3">MDL Call</span></p><ul class="c12 lst-kix_6zxsc1mlke1b-0 start"><li class="c1 c18 li-bullet-0"><span class="c9">Hold and answer call phone 8am-5pm</span></li><li class="c1 c18 li-bullet-0"><span>Manage Molecular Sendout Log (see </span><span class="c6 c15"><a class="c14" href="#h.f8wedwkh0s6n">MDL call</a></span><span class="c9">&nbsp;section)</span></li></ul><p class="c1 c24 c4"><span class="c9"></span></p><p class="c1"><span class="c3">Myeloseq &amp; Chromoseq</span></p><ul class="c12 lst-kix_5f4ryaaz99dq-0 start"><li class="c1 c18 li-bullet-0"><span class="c9">Complete assigned Myeloseq and Chromoseq interpretations before signout each week</span></li><li class="c1 c18 li-bullet-0"><span class="c9">Myeloseq and Chromoseq signout are at 2pm on Friday</span></li><li class="c1 c18 li-bullet-0"><span class="c9">Cases will be assigned Monday or Tuesday and become available for interpretation Wednesday or Thursday</span></li></ul><p class="c1 c24 c4"><span class="c9"></span></p><p class="c1"><span class="c3">Presentations</span></p><ul class="c12 lst-kix_8msg9554alny-0 start"><li class="c1 c18 li-bullet-0"><span class="c6">LGM Case conference</span><span class="c9">: One 25 min presentation in front of all LGM. Focus on clinical case, diagnosis, and lit review.</span></li><li class="c1 c18 li-bullet-0"><span class="c6">Heme Genomics Conference</span><span class="c9">: One 25min presentation in front of Hematopathology and Molecular divisions. Focus on hematopathology topic.</span></li><li class="c1 c18 li-bullet-0"><span class="c6">Tuesday Molecular Didacti</span><span>c: Two up-to-1-hour presentations in front of the molecular residents +/- fellow. The first topic will be assigned. The second you choose from the </span><span class="c6 c15"><a class="c14" href="https://www.google.com/url?q=https://link.springer.com/book/10.1007/978-3-642-19677-5&amp;sa=D&amp;source=editors&amp;ust=1697833802382178&amp;usg=AOvVaw1aRn4u9yrCf9ABb__GPujD">DMPP textbook</a></span><span class="c9">.</span></li><li class="c1 c18 li-bullet-0"><span class="c6">Beeper Report</span><span class="c9">: One presentation for each week you&rsquo;re on MDL call. Discussion of new acute leukemias (AML/ALL), new acute leukemia relapses, and non-hematologic sendout testing.</span></li></ul><h2 class="c7" id="h.ajk3ddkrgmav"><span class="c20 c28">Navigating Sharepoint</span></h2><p class="c1"><span class="c9">It&rsquo;s chaos y&rsquo;all. Use the search bar.</span></p><p class="c1 c4"><span class="c26 c17"></span></p><h1 class="c23" id="h.ozsgdk265297"><span class="c21 c20">Molecular Diagnostics Lab (MDL)</span></h1><h3 class="c10" id="h.f8wedwkh0s6n"><span class="c2">MDL Call</span></h3><p class="c1"><span class="c17">Managing the </span><span class="c6 c15 c17"><a class="c14" href="https://www.google.com/url?q=https://path.wustl.edu/sendoutlog/Trainee/MyWorklist&amp;sa=D&amp;source=editors&amp;ust=1697833802383282&amp;usg=AOvVaw3MmTCx-SzxwnIxbiMv5nEd">Sendout Log</a></span></p><p class="c1"><span class="c9">New cases appear in the &ldquo;Pending&rdquo; tab. You should click them and hit [update] button to add them to your queue. Your queue is in the &ldquo;My Worklist&rdquo; tab. Organize your worklist by sorting the cases by &ldquo;Id.&rdquo; You should address new cases 2-3 times per day and run the entire Worklist daily to check for updates. Before closing a case, if there are relevant biopsies or cytogenetics/FISH in CoPath, the attendings like these results recorded in the log. Tests that were already auto-approved do not bear thinking about, just hit the &ldquo;approve&rdquo; button and move on. It is normal for cases to drag out for several days awaiting bone marrow and FISH/cytogenetic results.</span></p><p class="c1 c4"><span class="c9"></span></p><p class="c1"><span class="c9">Cases will fall into three categories: Hematologic molecular algorithm (HMA), hematologic non-HMA, and non-hematologic. </span></p><p class="c1 c4"><span class="c9"></span></p><p class="c1 c24"><span class="c9">HMA cases are characterized by an HMA order. follow the instructions in the HMA for them. </span></p><p class="c1 c24 c4"><span class="c9"></span></p><p class="c1 c24"><span class="c9">Hematologic non-HMA cases are characterized by hematologic orders such as FLT3 or Myeloseq, but no HMA order. For these you should approve if indicated by the HMA, or if not indicated by the HMA, ask the clinicians what they&rsquo;re looking for and whether they&rsquo;d like to change to testing indicated by the HMA. If there is no HMA order, you cannot add additional testing, so if the clinician wants it, they must order it. </span></p><p class="c1 c24 c4"><span class="c9"></span></p><p class="c1 c24"><span>Non-hematologic cases involve miscellaneous sendout tests. These are similar to test approvals from chemistry and micro, but for the fact that we rarely say &ldquo;no.&rdquo; Information on what you should do with these may be found herein (</span><span class="c6 c15"><a class="c14" href="#h.63fntkqzyzpf">Molecular Sendout Testing (alphabetical order)</a></span><span>) or if you search historical cases in the call log.</span></p><h2 class="c27" id="h.nx0fwq1al5e1"><span class="c28 c20">Hematologic Molecular Algorithm (HMA)</span></h2><h3 class="c10" id="h.p27u1n7bawyb"><span class="c2">Chromoseq</span></h3><h3 class="c10" id="h.b3rjvrxu75bb"><span class="c2">Clonoseq</span></h3><h3 class="c10" id="h.bhd37n9yfnmd"><span class="c2">FLT3</span></h3><h3 class="c10" id="h.hj8biuoni1yg"><span class="c2">Myeloseq</span></h3><h3 class="c10" id="h.40ecygjfzu2r"><span class="c2">Tempus</span></h3><h2 class="c27" id="h.63fntkqzyzpf"><span class="c28 c20">Molecular Sendout Testing (alphabetical order)</span></h2><h3 class="c10" id="h.ob6ahw6piz0m"><span class="c2">Apolipoprotein E</span></h3><p class="c1"><span class="c5">Testing laboratory: MAYO</span></p><p class="c1"><span class="c25">Test ID: </span><span class="c5">APOEG</span></p><p class="c1"><span class="c25">Link: </span><span class="c6 c25 c15"><a class="c14" href="https://www.google.com/url?q=https://www.mayocliniclabs.com/test-catalog/Overview/35358&amp;sa=D&amp;source=editors&amp;ust=1697833802385925&amp;usg=AOvVaw2wiksIMuXf7caZXldymgSn">https://www.mayocliniclabs.com/test-catalog/Overview/35358</a></span><span class="c25">&nbsp;</span></p><p class="c1"><span class="c25 c17">Indication:</span><span class="c25">&nbsp;</span><span class="c25">Appropriate in individuals undergoing treatment or planning to undergo treatment with </span><span class="c25 c20 c33">lecanemab.</span></p><p class="c1 c4"><span class="c9"></span></p><h3 class="c10" id="h.g0v069w1pmuk"><span class="c2">Apolipoprotein L1</span></h3><p class="c1"><span class="c5">Testing laboratory: MAYO</span></p><p class="c1"><span class="c5">Test ID: APOL1</span></p><p class="c0"><span class="c25">Link: </span><span class="c6 c25 c15"><a class="c14" href="https://www.google.com/url?q=https://www.mayocliniclabs.com/test-catalog/Overview/605251&amp;sa=D&amp;source=editors&amp;ust=1697833802386870&amp;usg=AOvVaw3WbJQbWYtd0KNUplwHg4Qp">https://www.mayocliniclabs.com/test-catalog/Overview/605251</a></span><span class="c5">&nbsp;</span></p><p class="c0"><span class="c25 c17">Indication: </span><span class="c5">Variants associated with development of kidney disease. Appropriate in African americans undergoing kidney disease workup or in individuals who will be kidney donors.</span></p><p class="c1 c4"><span class="c9"></span></p><h3 class="c10" id="h.5w6ymsreoh2t"><span class="c2">CYP450 family sequencing</span></h3><h3 class="c10" id="h.rkhw4fiquozv"><span class="c2">DPYD Genotype</span></h3><h3 class="c10" id="h.scwhztbhe897"><span class="c2">Huntington Disease Genetic Testing</span></h3><p class="c4 c13"><span class="c11"></span></p><h1 class="c23" id="h.g16feqege86v"><span class="c21 c20">Next Generation Sequencing (NGS)</span></h1><h3 class="c10" id="h.9zwhjumms2iw"><span class="c2">Myeloseq</span></h3><p class="c1"><span class="c6 c15"><a class="c14" href="https://www.google.com/url?q=https://hughes-drew.github.io/intro_to_myeloseq.html&amp;sa=D&amp;source=editors&amp;ust=1697833802388054&amp;usg=AOvVaw1q556cYClNVq2G_eT-L4S6">Dr. Hughes&rsquo; Introduction</a></span><span class="c9">&nbsp;is very good.</span></p><p class="c1 c4"><span class="c9"></span></p><p class="c1"><span class="c3">Setup Myeloreporter</span></p><p class="c1"><span>Go to </span><span class="c30 c20 c31">\\pathfiles.wustl.edu/amp/Genomics/Myeloseq_Results/Myeloreporter</span></p><p class="c1"><span>Copy</span><span class="c19">&nbsp;</span><span class="c30">index.html</span><span class="c19">&nbsp;</span><span class="c9">into your browser. Bookmark this link so you can access it quickly in future.</span></p><p class="c1 c4"><span class="c9"></span></p><p class="c1"><span class="c3">Interpret Myeloseq</span></p><p class="c1"><span class="c9">Click [Choose File]</span></p><p class="c1"><span class="c9">Select from </span></p><h3 class="c10" id="h.cicg7ym4qsgc"><span class="c2">Chromoseq</span></h3><h3 class="c10" id="h.th2pfcqzuiwd"><span class="c2">Cytogenetics</span></h3><p class="c1 c4"><span class="c26 c17"></span></p></body></html>
